TDOC Teladoc Health, Inc. Common Stock
حول Teladoc Health, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
اقرأ المزيد
Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.
The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.
History
2002–2015
Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.
Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.
2015–2016
Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.
In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.
In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.
2017–2020
In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.
On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.
Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.
In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.
2021–2024
In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.
On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.
Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.
In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.
In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.
2025–present
In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.
In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.
The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.
Services and business model
Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.
Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.
By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.
Disaster aid
Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.
Lobbying and legislation
Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.
In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.
In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
TDOC لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
TDOC مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
TDOC توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 4 12,9%
- شراء 7 22,6%
- احتفاظ 20 64,5%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
19 محللين · 2026-08-14سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.21 | $-0.25 | 0.04% |
| 31 مارس، 2026 | $-0.36 | $-0.32 | -0.04% |
| 31 ديسمبر، 2025 | $-0.14 | $-0.19 | 0.05% |
| 30 سبتمبر، 2025 | $-0.28 | $-0.27 | -0.01% |
| 30 يونيو، 2025 | $-0.19 | $-0.27 | 0.08% |
| 31 مارس، 2025 | $-0.53 | $-0.34 | -0.19% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
| EVH | — | -0.8 | -26.6% | -28.5% | -81.5% | — |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 18
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
التدفق النقدي 18
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
الربحية 8
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
السيولة والملاءة 5
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
قائمة الدخل 17
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
الميزانية العمومية 25
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
التدفق النقدي 12
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
السيولة والملاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
الكفاءة 3
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
التقييم (آخر 12 شهرًا) 9
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.50B | · | $2.53B | $2.54B | $2.56B | · | $2.59B | $2.60B | $2.59B | · | $2.55B | $2.49B | $2.40B | · | $2.29B | |
| Net Income TTM | $-185M | $-239M | · | $-208M | $-997M | $-1.05B | · | $-1.01B | $-1.04B | $-273M | · | $-265M | $-3.31B | $-9.92B | · | $-9.93B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.2 | -4.0 | · | -6.5 | -1.5 | -1.3 | · | -1.5 | -1.6 | -9.1 | · | -11.5 | -1.2 | -0.4 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.7 | 1.8 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| P / FCF | · | 125.2 | · | · | · | 105.8 | · | · | · | 329.0 | · | · | · | 393.4 | · | · | |
| Earnings Yield | -12.3% | -24.9% | · | -15.4% | -66.9% | -77.0% | · | -64.8% | -63.0% | -11.0% | · | -8.7% | -80.9% | -238.1% | · | -243.7% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| هامش الربح التشغيلي % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| صافي الدخل | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| EPS المخفف | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | — | — | — | — | 0.0 |
| النسبة الحالية | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| النسبة السريعة | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $285M | $283M | $339M | $173M | $185M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 398 مقدمي إقرار · $1.2B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 73 (+11 مقابل الربع السابق) | 33 (-40 مقابل الربع السابق) | 104 (-10 مقابل الربع السابق) | 88 (+3 مقابل الربع السابق) | +36.3M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $139930938 | 19990134 | 11,50% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107573820 | 12685592 | 8,84% | الأسهم |
| Point72 Asset Management, L.P. | $69874581 | 8239927 | 5,74% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $68457700 | 8072842 | 5,63% | الأسهم |
| Voss Capital, LP | $68235838 | 8046679 | 5,61% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $67458671 | 7955032 | 5,55% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $59415442 | 7006538 | 4,88% | الأسهم |
| STATE STREET CORP | $42080999 | 4962382 | 3,46% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $41505394 | 4894504 | 3,41% | الأسهم |
| Allianz Asset Management GmbH | $39572734 | 4666596 | 3,25% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $33651520 | 3967415 | 2,77% | الأسهم |
| Monaco Asset Management SAM | $26864462 | 3167979 | 2,21% | الأسهم |
| JUPITER ASSET MANAGEMENT LTD | $26370375 | 3109714 | 2,17% | الأسهم |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25976377 | 3063252 | 2,14% | الأسهم |
| GOLDMAN SACHS GROUP INC | $25430579 | 2998889 | 2,09% | الأسهم |
| Quantinno Capital Management LP | $23904416 | 2818917 | 1,97% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17299632 | 2040051 | 1,42% | الأسهم |
| AMERIPRISE FINANCIAL INC | $16946398 | 1998396 | 1,39% | الأسهم |
| Pale Fire Capital SE | $16737502 | 1973762 | 1,38% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16435088 | 1938100 | 1,35% | عقد خيار الشراء |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11710032 | 1380900 | 0,96% | عقد خيار البيع |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11348708 | 1338291 | 0,93% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $10120074 | 1193405 | 0,83% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $9796800 | 1155283 | 0,81% | الأسهم |
| Freestone Grove Partners LP | $7338160 | 865349 | 0,60% | الأسهم |
| Man Group plc | $6880545 | 811385 | 0,57% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $6795228 | 801324 | 0,56% | الأسهم |
| CITADEL ADVISORS LLC | $6795024 | 801300 | 0,56% | عقد خيار البيع |
| Union Square Park Capital Management, LLC | $6784000 | 800000 | 0,56% | الأسهم |
| CITADEL ADVISORS LLC | $6532093 | 770294 | 0,54% | الأسهم |
| FMR LLC | $6418334 | 756879 | 0,53% | الأسهم |
| TCW GROUP INC | $6248039 | 736797 | 0,51% | الأسهم |
| Voss Capital, LP | $5936000 | 700000 | 0,49% | عقد خيار الشراء |
| Empowered Funds, LLC | $5764619 | 679790 | 0,47% | الأسهم |
| PEAK6 LLC | $5227920 | 616500 | 0,43% | عقد خيار الشراء |
| CITADEL ADVISORS LLC | $5114288 | 603100 | 0,42% | عقد خيار الشراء |
| Squarepoint Ops LLC | $5089696 | 600200 | 0,42% | عقد خيار الشراء |
| JANE STREET GROUP, LLC | $5088848 | 600100 | 0,42% | عقد خيار البيع |
| FRANKLIN RESOURCES INC | $4518161 | 532802 | 0,37% | الأسهم |
| TWO SIGMA ADVISERS, LP | $4211319 | 601617 | 0,35% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3700706 | 436404 | 0,30% | الأسهم |
| WOLVERINE TRADING, LLC | $3607180 | 439900 | 0,30% | عقد خيار الشراء |
| Parallax Volatility Advisers, L.P. | $3392000 | 400000 | 0,28% | عقد خيار الشراء |
| TUDOR INVESTMENT CORP ET AL | $3288603 | 387807 | 0,27% | الأسهم |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $3248866 | 383121 | 0,27% | الأسهم |
| Swiss National Bank | $3035857 | 358002 | 0,25% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $2894928 | 341383 | 0,24% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $2781435 | 510355 | 0,23% | الأسهم |
| Squarepoint Ops LLC | $2761936 | 325700 | 0,23% | عقد خيار البيع |
| Trexquant Investment LP | $2755932 | 324992 | 0,23% | الأسهم |
| D. E. Shaw & Co., Inc. | $2544000 | 300000 | 0,21% | عقد خيار البيع |
| ORACLE INVESTMENT MANAGEMENT INC | $2480366 | 354338 | 0,20% | الأسهم |
| Soviero Asset Management, LP | $2442240 | 288000 | 0,20% | عقد خيار الشراء |
| D. E. Shaw & Co., Inc. | $2371941 | 279710 | 0,20% | الأسهم |
| BlackRock, Inc. | $2312106 | 272654 | 0,19% | الأسهم |
| IEQ CAPITAL, LLC | $2273165 | 268062 | 0,19% | الأسهم |
| JANE STREET GROUP, LLC | $2155616 | 254200 | 0,18% | عقد خيار الشراء |
| WOLVERINE TRADING, LLC | $2059020 | 251100 | 0,17% | عقد خيار البيع |
| RHUMBLINE ADVISERS | $2058803 | 242785 | 0,17% | الأسهم |
| Walleye Trading LLC | $2017188 | 237876 | 0,17% | الأسهم |
| WINTON GROUP Ltd | $1925808 | 227100 | 0,16% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1906796 | 224858 | 0,16% | الأسهم |
| Brevan Howard Capital Management LP | $1880084 | 221708 | 0,15% | الأسهم |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1704675 | 243525 | 0,14% | الأسهم |
| UBS Group AG | $1696000 | 200000 | 0,14% | عقد خيار الشراء |
| NOMURA HOLDINGS INC | $1696000 | 200000 | 0,14% | عقد خيار البيع |
| Parker Investment Management, LLC | $1586515 | 187089 | 0,13% | الأسهم |
| OPPENHEIMER & CO INC | $1571268 | 185291 | 0,13% | الأسهم |
| ABS Direct Equity Fund LLC | $1513154 | 178438 | 0,12% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1495703 | 274441 | 0,12% | الأسهم |
| Summit Trail Advisors, LLC | $1488766 | 175562 | 0,12% | الأسهم |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $1484000 | 175000 | 0,12% | الأسهم |
| SIMPLEX TRADING, LLC | $1396808 | 164718 | 0,11% | الأسهم |
| BARCLAYS PLC | $1347861 | 158946 | 0,11% | الأسهم |
| NATIXIS | $1347472 | 158900 | 0,11% | الأسهم |
| WELLS FARGO & COMPANY/MN | $1346183 | 158748 | 0,11% | الأسهم |
| JENNISON ASSOCIATES LLC | $1333793 | 157287 | 0,11% | الأسهم |
| Rock Creek Group LLC | $1329944 | 156833 | 0,11% | الأسهم |
| MACKENZIE FINANCIAL CORP | $1297381 | 152993 | 0,11% | الأسهم |
| Walleye Trading LLC | $1277936 | 150700 | 0,11% | عقد خيار البيع |
| Counterpoint Mutual Funds LLC | $1252301 | 147677 | 0,10% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $1233111 | 145414 | 0,10% | الأسهم |
| Balyasny Asset Management L.P. | $1226208 | 144600 | 0,10% | عقد خيار البيع |
| TWO SIGMA INVESTMENTS, LP | $1217245 | 143543 | 0,10% | الأسهم |
| ALGERT GLOBAL LLC | $1211792 | 142900 | 0,10% | الأسهم |
| Engineers Gate Manager LP | $1204499 | 142040 | 0,10% | الأسهم |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1187666 | 140055 | 0,10% | الأسهم |
| Walleye Capital LLC | $1082896 | 127700 | 0,09% | عقد خيار الشراء |
| Leonteq Securities AG | $1064384 | 125517 | 0,09% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $1045813 | 123327 | 0,09% | الأسهم |
| JANUS HENDERSON GROUP PLC | $1038988 | 190640 | 0,09% | الأسهم |
| Walleye Capital LLC | $989616 | 116700 | 0,08% | عقد خيار البيع |
| Crawford Fund Management, LLC | $987072 | 116400 | 0,08% | عقد خيار البيع |
| OP Asset Management Ltd | $958969 | 113086 | 0,08% | الأسهم |
| Vanguard Global Advisers, LLC | $932469 | 109961 | 0,08% | الأسهم |
| CHIRON CAPITAL MANAGEMENT, LLC | $930850 | 109770 | 0,08% | الأسهم |
| Jefferies Financial Group Inc. | $907657 | 107035 | 0,07% | الأسهم |
| MetLife Investment Management, LLC | $901746 | 106338 | 0,07% | الأسهم |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $891845 | 96104 | 0,07% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $876815 | 103398 | 0,07% | الأسهم |
المطلعون على الشركة 48 من المطلعين · مسؤولون 23 · مديرون 22
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 10 يونيو، 2026 M | 414622 | 0 | 6 | $-938572 |
| Jason N Gorevic | Chief Executive Officer | 4 مارس، 2022 M | 516464 | 0 | 0 | $0 |
| Mala Murthy | Chief Financial Officer | 1 مارس، 2022 A | 17357 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 13 ديسمبر، 2018 M | 10000 | 0 | 0 | $0 |
| Kelly Bliss | President, U.S. Group Health | 6 يوليو، 2026 S | 84878 | 0 | 4 | $-126068 |
| Fernando M. Rodrigues | President of BetterHelp | 3 يونيو، 2026 S | 0 | 0 | 2 | $-114131 |
| Carlos Nueno | President, International | 1 يونيو، 2026 M | 57671 | 0 | 1 | $-47257 |
| Peter A Mcclennen | President | 15 يوليو، 2019 M | 0 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 29 يوليو، 2021 M | 11031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 1 يوليو، 2026 M | 12267 | 0 | 2 | $-8108 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 1 يونيو، 2026 M | 110261 | 0 | 3 | $-241831 |
| Daniel Trencher | SVP Corporate Strategy | 4 مارس، 2022 M | 29408 | 0 | 0 | $0 |
| Stephany Verstraete | Chief Marketing Officer | 4 مارس، 2022 M | 31828 | 0 | 0 | $0 |
| Andrew Turitz | SVP - Business Development | 4 مارس، 2022 M | 14794 | 0 | 0 | $0 |
| Claus Torp Jensen | Chief Innovation Officer | 1 مارس، 2022 A | — | 0 | 0 | $0 |
| Arnnon Geshuri | Chief Human Resources Officer | 1 مارس، 2022 A | 83168 | 0 | 0 | $0 |
| Richard J Napolitano | Chief Accounting Officer | 1 مارس، 2022 A | 1195 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 1 أكتوبر، 2020 M | 8766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 1 سبتمبر، 2020 M | 3232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 1 يوليو، 2020 A | — | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 16 إبريل، 2020 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 25 مايو، 2017 A | 61459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 13 مارس، 2017 A | — | 0 | 0 | $0 |
| Mark V Anquillare | مدير | 3 أغسطس، 2026 A | — | 0 | 0 | $0 |
| David B Snow JR | مدير | 21 مايو، 2026 A | 113032 | 0 | 0 | $0 |
| David L Shedlarz | مدير | 21 مايو، 2026 A | 61266 | 0 | 0 | $0 |
| Susan R Salka | مدير | 30 مارس، 2026 A | — | 0 | 0 | $0 |
| Catherine Jacobson | مدير | 18 فبراير، 2022 M | 1468 | 0 | 0 | $0 |
| William H. Frist | مدير | 15 سبتمبر، 2021 M | 12918 | 0 | 0 | $0 |
| Karen L Daniel | مدير | 25 أغسطس، 2021 M | 41915 | 0 | 0 | $0 |
| Christopher Bischoff | مدير | 25 مايو، 2021 M | 5121 | 0 | 0 | $0 |
| Mark Douglas Smith | مدير | 17 مايو، 2021 A | 3536 | 0 | 0 | $0 |
| Kenneth H Paulus | مدير | 17 مايو، 2021 A | 0 | 0 | 0 | $0 |
| Thomas Mckinley | مدير | 17 مايو، 2021 A | 5879 | 0 | 0 | $0 |
| Hemant Taneja | مدير | 19 إبريل، 2021 S | 118760 | 0 | 0 | $0 |
| Glen Tullman | مدير | 1 إبريل، 2021 M | 275793 | 0 | 0 | $0 |
| Helen Darling | مدير | 11 يونيو، 2020 M | 918 | 0 | 0 | $0 |
| Arneek Multani | مدير | 30 مايو، 2019 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | مدير | 30 مايو، 2019 A | 1965 | 0 | 0 | $0 |
| Tom Mawhinney | مدير | 25 مايو، 2018 M | 46203 | 0 | 0 | $0 |
| Martin R Felsenthal | مدير | 8 أغسطس، 2016 A | 10860 | 0 | 0 | $0 |
| Dana G Mead Jr. | مدير | 8 أغسطس، 2016 A | 202 | 0 | 0 | $0 |
| James K Outland | مدير | 13 يوليو، 2015 M | 49986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | مالك 10% | 26 إبريل، 2017 J | 2480468 | 0 | 0 | $0 |
| CHP III LP | مالك 10% | 26 إبريل، 2017 J | 2480468 | 0 | 0 | $0 |
| Sandra L Fenwick | — | 21 مايو، 2026 A | 10762 | 0 | 0 | $0 |
| Yulun Wang | — | 25 يناير، 2021 S | 219507 | 0 | 0 | $0 |
| Michael Goldstein | — | 11 يونيو، 2020 M | 0 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 2 حيازتان
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 إيداعات | 15 إبريل، 2021 | — | إيداع أولي | — | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 إيداعات | 16 مارس، 2021 | — | إيداع أولي | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 55 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| HEAL · Global X Funds | 1,18% | 38782 NS | 31 مايو، 2026 | N-PORT |
| SVAL · iShares Trust | 0,42% | 129925 SH | 8 أغسطس، 2026 | يومي |
| JSML · Janus Detroit Street Trust | 0,34% | 178607 NS | 30 إبريل، 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 261035 NS | 31 مايو، 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,18% | 66764 NS | 31 مايو، 2026 | N-PORT |
| IHF · iShares Trust | 0,18% | 332174 SH | 8 أغسطس، 2026 | يومي |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,10% | 159976 SH | 8 أغسطس، 2026 | يومي |
| SMLF · iShares Trust | 0,09% | 592154 SH | 8 أغسطس، 2026 | يومي |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 978669 NS | 31 مايو، 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2910344 NS | 31 مايو، 2026 | N-PORT |
| IWN · iShares Trust | 0,08% | 1690654 SH | 8 أغسطس، 2026 | يومي |
| GINN · Goldman Sachs ETF Trust | 0,08% | 21242 NS | 31 مايو، 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,07% | 920742 NS | 30 إبريل، 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,07% | 155542 NS | 30 إبريل، 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 252145 NS | 31 مايو، 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 67673 NS | 30 إبريل، 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1047849 SH | 8 أغسطس، 2026 | يومي |
| VFMF · VANGUARD WELLINGTON FUND | 0,04% | 29737 SH | 8 أغسطس، 2026 | يومي |
| IWM · iShares Trust | 0,04% | 4666989 SH | 8 أغسطس، 2026 | يومي |
| ISCV · iShares Trust | 0,04% | 38629 SH | 8 أغسطس، 2026 | يومي |
| PNQI · Invesco Exchange-Traded Fund Trust | 0,04% | 26986 SH | 8 أغسطس، 2026 | يومي |
| ITWO · ProShares Trust | 0,03% | 8377 NS | 31 مايو، 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 77120 NS | 30 إبريل، 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2631374 SH | 8 أغسطس، 2026 | يومي |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 858463 NS | 31 مايو، 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 584184 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2084219 SH | 8 أغسطس، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | 0,02% | 4153113 SH | 8 أغسطس، 2026 | يومي |
| UWM · ProShares Trust | 0,02% | 6552 NS | 31 مايو، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 535056 SH | 8 أغسطس، 2026 | يومي |
| ISCB · iShares Trust | 0,02% | 7717 SH | 8 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 81058 NS | 30 إبريل، 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 10585 NS | 30 إبريل، 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 6629 NS | 31 مايو، 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 285019 NS | 30 إبريل، 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 170044 SH | 8 أغسطس، 2026 | يومي |
| WSML · iShares Trust | 0,01% | 10387 SH | 8 أغسطس، 2026 | يومي |
| TILT · FlexShares Trust | 0,01% | 34034 NS | 30 إبريل، 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 6863 NS | 31 مايو، 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 166 NS | 31 مايو، 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 422235 NS | 30 إبريل، 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 9970 NS | 31 مايو، 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,01% | 1783 NS | 31 مايو، 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 22871 NS | 30 إبريل، 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 11743 NS | 30 إبريل، 2026 | N-PORT |
| DSI · iShares Trust | 0,00% | 25216 SH | 8 أغسطس، 2026 | يومي |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 42456 NS | 31 مايو، 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 105579 NS | 31 مايو، 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 232888 SH | 8 أغسطس، 2026 | يومي |
| IWV · iShares Trust | 0,00% | 45271 SH | 8 أغسطس، 2026 | يومي |